Background Tuberculosis (TB) remains a leading cause of morbidity and mortality in Nigeria, particularly among people living ...

Objective SLE is a multisystem autoimmune disease characterised by chronic inflammation and progressive organ damage, ...

Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced financial results for its second quarter ended June 30, 2025 and updated its ...